CoChat

Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth

Open access
Vindrieux, David, Devailly, Guillaume, Augert, Arnaud, Le Calvé, Benjamin, Ferrand, Mylène, Pigny, Pascal, Payen, Léa, Lambeau, Gérard, Perrais, Michael, Aubert, Sébastien, Simonnet, Hélène, Dante, Robert, Bernard, David · 2014 · Oncotarget
Cited by 42

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

// David Vindrieux 1,2,3,4 , Guillaume Devailly 1,2,3,4 , Arnaud Augert 1,2,3,4 , Benjamin Le Calvé 1,2,3,4 , Mylène Ferrand 1,2,3,4 , Pascal Pigny 5,6 , Léa Payen 1,2,3,4 , Gérard Lambeau 7 , Michael Perrais 5 , Sébastien Aubert 5,8 , Hélène Simonnet 1,2,3,4 , Robert Dante 1,2,3,4 and David Bernard 1,2,3,4 1 Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France; 2 CNRS UMR5286, Lyon France; 3 Centre Léon Bérard, Lyon, France; 4 Université de Lyon, Lyon, France; 5 INSERM U837, Jean-Pierre Aubert Research Center, Lille, France; 6 Institut de Biochimie et Biologie Moléculaire Centre de Biologie Pathologie CHRU Lille, Lille, France; 7 Institut de Pharmacologie Moléculaire et Cellulaire, UMR6097, CNRS and Université de Nice-Sophia Antipolis, Valbonne, France; 8 Institut de Pathologie, CHRU, Faculté de Médecine, Université de Lille, Lille, France. Correspondence: David Bernard, email: // Keywords : VHL; MYC; HIF; PLA2R1; tumor suppressor Received : December 11, 2013 Accepted : January 16, 2014 Published : January 16, 2014 Abstract Loss of secreted phospholipase A2 receptor (PLA2R1) has recently been found to render human primary cells more resistant to senescence whereas increased PLA2R1 expression is able to induce cell cycle arrest, cancer cell death or blockage of cancer cell transformation in vitro, suggesting that PLA2R1 displays tumor suppressive activities. Here we report that PLA2R1 expression strongly decreases in samples of human renal cell carcinoma (RCC). Knockdown of PLA2R1 increases renal cancer cell tumorigenicity supporting a role of PLA2R1 loss to promote in vivo RCC growth. Most RCC result from Von Hippel-Lindau (VHL) tumor suppressor loss-of-function and subsequent gain-of-function of the oncogenic HIF-2alpha/c-MYC pathway. Here, by genetically manipulating VHL, HIF-2alpha and c-MYC, we demonstrate that loss of VHL, stabilization of HIF-2alpha and subsequent increased c-MYC activity, binding and transcriptional repression, through induction of PLA2R1 DNA methylation closed to PLA2R1 transcriptional start site, results in decreased PLA2R1 transcription. Our results describe for the first time an oncogenic pathway leading to PLA2R1 transcriptional repression and the importance of this repression for tumor growth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.1681

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 42

Metadata

Authors
Vindrieux, D., Devailly, G., Augert, A., Le Calvé, B., Ferrand, M., Pigny, P., Payen, L., Lambeau, G., Perrais, M., Aubert, S., Simonnet, H., Dante, R., & Bernard, D.
Venue
Oncotarget
Published
2014-01-16
Volume
5
Issue
4
Pages
1004-1013
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1900137947
Cited by
42
References
11
FWCI
1.07
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth. https://app.cochat.ai/papers/10.18632/oncotarget.1681
The paper
Vindrieux, D., Devailly, G., Augert, A., Le Calvé, B., Ferrand, M., Pigny, P., Payen, L., Lambeau, G., Perrais, M., Aubert, S., Simonnet, H., Dante, R., & Bernard, D. (2014). Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth. Oncotarget. https://doi.org/10.18632/oncotarget.1681

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.